The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD

A. Kadushkin (Minsk, Belarus), A. Tahanovich (Minsk, Belarus), ?. Kolesnikova (Minsk, Belarus), E. Hodosovskaya (Minsk, Belarus), E. Talabayeva (Minsk, Belarus), A. Plastinina (Minsk, Belarus)

Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Session: New insights into the airway immunology of lung disease
Session type: E-poster
Number: 685

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kadushkin (Minsk, Belarus), A. Tahanovich (Minsk, Belarus), ?. Kolesnikova (Minsk, Belarus), E. Hodosovskaya (Minsk, Belarus), E. Talabayeva (Minsk, Belarus), A. Plastinina (Minsk, Belarus). The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD. 685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of smoking on the level of proinflammatory cytokines in patients with COPD
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012


Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

Proinflammatory cytokines in induced sputum and COPD phenotype
Source: Annual Congress 2011 - COPD: human studies
Year: 2011

The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016

The levels of proinflammatory cytokines in patients with dust-induced lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 536s
Year: 2001

An evaluation of circulating cytokines milieu in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 311s
Year: 2002

Involvement of nitric oxide, proinflammatory cytokines and effector cells in the inflammatory process in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Impact of cytokines on endothelium in COPD patients
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021

Local and systemic imbalance of pro- and antiinflammatory cytokines in COPD
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009

Effect of aerosolized antibiotics on proinflammatory cytokines
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002

Aerobic training inhibits leukocytes production of oxidants, pro-inflammatory and pro-fibrotic factors reducing asthmatic phenotype
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012


Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008


Macrolide effects on the prevention of COPD exacerbations
Source: Eur Respir J 2012; 40: 485-494
Year: 2012



Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019

Interdepedence between cytokines and antioxidants in lymphocytes of patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 590s
Year: 2005

Comparison of the effectiveness of azithromycin and budesonide versus theophylline and budesonide in the suppression of pro-inflammatory cytokines in patients with COPD
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


Microparticles from OSA patients induce hyper-reactivity through up-regulation of pro-inflammatory proteins
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006

Effects of treatment with N-acetylcysteine or inhaled corticosteroids on inflammatory mediators in COPD-patients
Source: Eur Respir J 2003; 22: Suppl. 45, 5s
Year: 2003